Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
2
Neutral
8
Bullish
4
Bearish
2
Neutral
8
Bullish
36
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Pharmaceuticals & Biotechnology
Pharmaceuticals
19 Cr
Low Risk
464.8
39.5
-1.8
2.4
4.15
2.23
Sales CAGR
Profit CAGR
ROE
ROCE
Investor Presentation
Q2 FY26
Zenith Health Care Ltd (ZENITHHE) is currently trading at 3.46 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Zenith Healthcare Limited is an India‑based integrated pharmaceutical manufacturer producing tablets, capsules, oral liquids, ointments and injectable formulations from its Changodar, Ahmedabad facility, operating under ISO 9001:2008 and WHO‑cGMP certifications and claiming dedicated lines for general and beta‑lactam products with stated installed capacities across dosage forms. The company reported standalone revenue from operations of Rs.226.66 lakhs in the quarter and Rs.541.77 lakhs for the half year ended September 30, 2025, with quarter net profit of Rs.14.18 lakhs and half‑year net profit of Rs.12.30 lakhs, indicating compressing profitability and lower half‑year profitability versus the prior corresponding period. Balance sheet and working capital movements are notable: inventories declined sharply from Rs.726.96 lakhs at March 31, 2025 to Rs.196.27 lakhs, trade receivables stayed comparable, while contract liabilities remain substantial at Rs.168.01 lakhs, and cash and bank balances reduced materially versus March 2025, signaling active revenue recognition and liquidity shifts. Operational footprint and capabilities are meaningful for a mid‑sized player: management cites manufacturing capacity to produce 168 million tablets, 39.5 million capsules and 80 million liquids annually, isolated production lines for beta‑lactam and general formulations, and focus on quality and adherence to delivery schedules, implying positioning as a flexible contract manufacturer or regional supplier. Cash flow and capital activity show negative operating cash flow of Rs.32.85 lakhs for the half year, modest capex of Rs.15.32 lakhs, a large loans and advances movement to Rs.200 lakhs, and net decrease in cash; these items highlight working capital strain, active intercompany or strategic lending, and limited free cash generation during the period.
Over the past 52 weeks, Zenith Health Care Ltd has traded between a low of ₹2.23 and a high of ₹4.15. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Zenith Health Care Ltd has a market capitalization of approximately 18.27. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Zenith Health Care Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 456.75 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 18.27 Cr, Zenith Health Care Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Zenith Health Care Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Zenith Health Care Ltd is 456.75. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Zenith Healthcare’s board is scheduled to consider and approve unaudited Q2 FY27 and half-year FY27 results on October 28, 2026.
The share price of Zenith Healthcare Ltd (ZENITHHE) was ₹3.18 as on 7 July 2026.
Zenith Healthcare Limited trades on the BSE under the ticker symbol ZENITHHE.
The share price of ZENITHHE was stated as ₹3.18 as on 7 July 2026.
